(1)
Evaluation of Serum Cystatin C As a Predictor of EGFR in Type 2 Diabetic Patients With Nephropathy. J Shalamar Med Dent Coll 2025, 6 (1), 03-08. https://doi.org/10.53685/jshmdc.v6i1.294.